SMTL ID : 6vhp.1

Wild type EGFR in complex with LN2899

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 3.60 Å

Oligo State

monomer

Ligands

1 x QP1: N-{3-[(4-{4-(4-fluorophenyl)-2-[(2-methoxyethyl)sulfanyl]-1H-imidazol-5-yl}pyridin-2-yl)amino]-4-methoxyphenyl}propanamide(Covalent)

QP1.1: 18 residues within 4Å: Chain A: L.23, F.28, V.31, A.48, K.50, M.71, L.82, L.93, I.94, T.95, Q.96, L.97, M.98, P.99, G.101, C.102, D.105, L.149 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:A.48, A:K.50, A:K.50, A:L.149 Hydrogen bonds: A:M.98, A:M.98, A:C.102

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Heppner, D.E. et al., Structural Basis for EGFR Mutant Inhibition by Trisubstituted Imidazole Inhibitors. J.Med.Chem. (2020)

Release Date

2020-04-22

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Epidermal growth factor receptor

Related Entries With Identical Sequence